Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3223]

Scientists identify new molecular strategies for tackling aggressive form of leukaemia

Scientists identify new molecular strategies for tackling aggressive form of leukaemia

Particles released by red blood cells are effective carriers for anti-cancer immunotherapy

Particles released by red blood cells are effective carriers for anti-cancer immunotherapy

Rewiring the biology of leukaemia cells to reverse drug resistance

Rewiring the biology of leukaemia cells to reverse drug resistance

AACR 2022: Leukaemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy

AACR 2022: Leukaemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy

AACR 2022: Novel COVID-19 vaccine may provide protection for cancer patients with B-cell deficiencies

AACR 2022: Novel COVID-19 vaccine may provide protection for cancer patients with B-cell deficiencies

AACR 2022: Some Latino children diagnosed with acute lymphoblastic leukaemia face higher risk of relapse compared to non-Latino white children

AACR 2022: Some Latino children diagnosed with acute lymphoblastic leukaemia face higher risk of relapse compared...

AACR 2022: Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients with advanced lymphoma

AACR 2022: Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients...

Patients with kidney disease may have an increased risk of cancer

Patients with kidney disease may have an increased risk of cancer

Third dose of COVID-19 vaccine increases immune responses most blood cancer patients, though some deficits remain

Third dose of COVID-19 vaccine increases immune responses most blood cancer patients, though some deficits remain

Vaccine protects most cancer patients from COVID, but risk remains higher for patients with blood cancers

Vaccine protects most cancer patients from COVID, but risk remains higher for patients with blood cancers

More from ecancer